1-5 of 5
drug effectiveness
Close
Sort by
Journal Articles

Effectiveness of Romiplostim for Treatment of Adults with Newly Diagnosed or Persistent Primary Immune Thrombocytopenia in US Clinical Practice

Mark Hatfield, PhD, Neel Shah, BPharm, PhD, Tatiana Lawrence, MD, Ahuva Hanau, BS, Alex Lonshteyn, PhD, Derek Weycker, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4668.
https://doi.org/10.1182/blood-2019-123999
Published: 2019
Journal Articles

Drug Sensitivity Screening on Multiple Myeloma for Precision Cancer Therapy

Deepak Balaji balaji Thimiri Govinda Raj, PhD MSc, Mariaserena Giliberto, Andrea Cremaschi, PhD MSc, Sigrid Strand Skånland, PhD, Alexandra Gade, Geir Erland Tjønnfjord, MD DMsc, Fredrik H. Schjesvold, MD PhD, Ludvig Andre Munthe, MD PhD, Kjetil Tasken
Journal: Blood
Blood (2018) 132 (Supplement 1): 4677.
https://doi.org/10.1182/blood-2018-99-110669
Published: 2018
Journal Articles

Patient-reported outcomes in hematology: is it time to focus more on them in clinical trials and hematology practice?

Clinical Trials & Observations
Fabio Efficace, Gianluca Gaidano, Francesco Lo-Coco
Journal: Blood
Blood (2017) 130 (7): 859–866.
https://doi.org/10.1182/blood-2017-03-737403
Published: 2017
Journal Articles

Venetoclax Resistant Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Cells Are Also Resistant to ABL Inhibitors, Which Can be Overcome By Targeting the PI3K/AKT/ mTOR Pathway

Jessica T Leonard, MD, Jeffrey W. Tyner, PhD, Joelle Rowley, Marc M. Loriaux, Brian J. Druker, Bill H. Chang, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1583.
https://doi.org/10.1182/blood.V128.22.1583.1583
Published: 2016
Journal Articles

In Vitro Chemosensitivity of Leukaemic Stem and Progenitor Cells to Gemtuzumab Ozogamicin (Mylotarg) in AML.

Mays Jawad, PhD, Ullas Mony, MSC, Nigel H. Russell, MBChB, Monica Pallis, PhD
Journal: Blood
Blood (2007) 110 (11): 650.
https://doi.org/10.1182/blood.V110.11.650.650
Published: 2007